Originally established as the venture capital arm of the Rockefeller family in 1969, Venrock partners with entrepreneurs to build some of the world’s most disruptive, successful companies. With a primary focus on technology and healthcare, portfolio companies include Apple Computer, Athenahealth, Centocor, Check Point Software, Dollar Shave Club, DoubleClick, Gilead Sciences, Idec Pharma, Imperva, Illumina, Intel, and Nest.
Foresite Capital is an uncommon mix of medical professionals, investment analysts and data scientists who believe that solving the world’s biggest healthcare problems requires a radically collaborative approach, free of arbitrary silos and competition. The company has created an atypical investment firm that funds companies at every part of their lifecycle, from early-stage through public liquidity, because company-building and value creation doesn’t stop at the IPO. With Foresite Capital, portfolio companies get dozens of experts and networks at their fingertips, each dedicated to their success over multiple decades. For more information, please visit http://www.foresitecapital.com/.
MLS Capital, co-managed by Spruce Capital Partners and Xeraya Capital, invests in a diversified portfolio of biogreentech companies at all stages of development. Biogreentech spans plant and animal agriculture; food, feed, and nutrition; bio-renewable chemicals and materials; and adjacent opportunities along the value chain, including “big data” analytics, robotics, production, harvesting and use of natural resources, and synthetic biology.
NanoDimension is a venture capital firm committed to building companies developing market-disruptive technologies on the nano scale. Founded in 2002, and with offices in Europe and the United States, NanoDimension focuses on early to mid-stage investments across business sectors.
Paladin is a multi-stage venture capital firm that invests in technology companies who are addressing a compelling private sector enterprise need while also advancing the broader public sector interest of resilience, safety and security. With over $1B of AUM and offices in Washington, DC, Silicon Valley, New York and London, Paladin currently manages over $1B globally with portfolio investments concentrated in enterprise IT, advanced semiconductor and life sciences.
Established in 2009, Mérieux Développement is an evergreen fund specialized in the healthcare sector, conducting growth and venture capital investments worldwide. Mérieux Développement works alongside entrepreneurs whose products and services can bring genuine advances to the health of patients and consumers, offering them access to its industry expertise and global network.